Andrew Stadvec

[Meg Tirrell @megtirrell]

$CVS says it expects increase in number of patients using Repatha & other PSCK9 inhibitors based on FOURIER

[Anna Wilde Mathews @annawmathews]

Our take on the Aetna-Humana antitrust ruling https://t.co/dTTQKs8xuN via @WSJ

[The Wall Street Journal @WSJ]

At Davos forum, IBM chief predicts artificial intelligence won’t be a job killer https://t.co/7iMNJADRr4

[Jane Sarasohn-Kahn @healthythinker]

The @US_FDA wkg w @IBMWatsonHealth on #blockchain for #healthcare #healthreg #pharma apps https://t.co/TRpHjHKKcu… https://t.co/T2yqaStSal

[Michael Seewald 🦞 @michael_seewald]

IBM Watson Health, FDA partner to improve healthcare data exchange - FirstWord Pharma https://t.co/FuY1UdWRmD via @fwpharma

[Andrew Stadvec @AndrewStadvec]

Pfizer finally convinces FDA to pull black-box warning on Chantix for psychotic side effects https://t.co/1RPq2KhsWE

[AJPB_Journal @AJPB_Journal]

BREAKING NEWS: #FDA Concludes #Diabetes Drug May Cause #BladderCancer https://t.co/jeLla20f49 #pioglitazone

[pharmalot @pharmalot]

Sanofi is cutting 20 percent of its US diabetes sales & marketing staffs.. details here.. https://t.co/1le9scm1Di #pharma #diabetes $SNY

[FiercePharma @FiercePharma]

Merck's Keytruda snags second FDA 'priority' tag this week, this time in Hodgkin's https://t.co/taFsil3tJB

[The Boston Globe @BostonGlobe]

Eli Lilly’s Alzheimer’s drug fails in late-stage trial, dashing hopes | via @StatNews https://t.co/jHoGxUYGmA

[ASHP @ASHPOfficial]

Popular heartburn medications have been linked to a higher risk of stroke https://t.co/hgbOVRGg5E

[AJMC @AJMC_Journal]

BLA for Bevacizumab Biosimilar Filed Based on Phase 3 NSCLC Data https://t.co/tShysHuBoW

[Xconomy @Xconomy]

.@IBMWatsonHealth and @broadinstitute Team Up for $50M #Cancer Collaboration | https://t.co/7Qd0DQw9Gu

[Adam Feuerstein ✡️ @adamfeuerstein]

$KITE — KTE-C19 BLA to be submitted in Q1 ’17.

[STAT @statnews]

You can now see which drug companies aren't sharing their clinical trial findings, thanks to this nifty tool: https://t.co/kACGnZpoIL

[Andrew Stadvec @AndrewStadvec]

NEJM: Opdivo/Yervoy combo can trigger potentially fatal heart failure as a side-effect: https://t.co/ySYvYcmLky

[Andrew Stadvec @AndrewStadvec]

IBM Watson Health partnering with Celgene to solve the drug-safety puzzle: https://t.co/lj5b8gi0Xp

[Andrew Stadvec @AndrewStadvec]

pricey PCSK-9 cholesterol drugs aren’t selling. And that has the biotech industry sweating https://t.co/m6bAXmCeVW

[FiercePharma @FiercePharma]

J&J clot fighter battles Pfizer/Bristol for warfarin switches in red-hot market share race https://t.co/UBXtaxZgUh

[Andrew Stadvec @AndrewStadvec]

Merck's Keytruda wins coveted first-line lung cancer nod https://t.co/hl8INAhGBa